These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1103575)

  • 21. Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study.
    Vanden Borre R; Vermote R; Buttiëns M; Thiry P; Dierick G; Geutjens J; Sieben G; Heylen S
    Acta Psychiatr Scand; 1993 Mar; 87(3):167-71. PubMed ID: 7682029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Double-blind study of difenoxin hydrochloride among travellers to tropical countries (author's transl)].
    Stransky M; Schwarzenbach FH
    Ther Umsch; 1979 Mar; 36(3):267-70. PubMed ID: 375457
    [No Abstract]   [Full Text] [Related]  

  • 25. Pipothiazine palmitate in the management of aggressive mentally handicapped patients.
    Lynch DM; Eliatamby CL; Anderson AA
    Br J Psychiatry; 1985 May; 146():525-9. PubMed ID: 2861874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical trial of a new psychopharmacological agent: piperonyl].
    Gazzaniga GC; Terzi GF
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Aug; 95(4):799-807. PubMed ID: 5114798
    [No Abstract]   [Full Text] [Related]  

  • 28. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.
    Goel G; King T; Daveson AJ; Andrews JM; Krishnarajah J; Krause R; Brown GJE; Fogel R; Barish CF; Epstein R; Kinney TP; Miner PB; Tye-Din JA; Girardin A; Taavela J; Popp A; Sidney J; Mäki M; Goldstein KE; Griffin PH; Wang S; Dzuris JL; Williams LJ; Sette A; Xavier RJ; Sollid LM; Jabri B; Anderson RP
    Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):479-493. PubMed ID: 28506538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Loss of visual acuity after treatment with pipamperone].
    Loos D; Kook P; Huber J; Zorn C; Lohmann CP; Zapp D; Maier M
    Ophthalmologe; 2011 Aug; 108(8):763-5. PubMed ID: 21717227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of milenperone on the aggressive behavior of oligophrenic patients. A double-blind placebo-controlled study.
    De Cuyper H; van Praag HM; Verstraeten D
    Neuropsychobiology; 1985; 13(3):101-5. PubMed ID: 3900796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the double-blind design in a study comparing lithium carbonate with placebo.
    Marini JL; Sheard MH; Bridges CI; Wagner E
    Acta Psychiatr Scand; 1976 May; 53(5):343-54. PubMed ID: 785950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential-pulse polarography determination of pipamperone in pharmaceutical formulations.
    Belgaied JE; Trabelsi H
    J Pharm Biomed Anal; 2002 Nov; 30(4):1417-23. PubMed ID: 12408934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study.
    Nygaard H; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K
    Pharmatherapeutica; 1988; 5(3):152-8. PubMed ID: 2896359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic drug monitoring of zuclopenthixol in a double-blind placebo-controlled discontinuation study in adults with intellectual disabilities and aggressive behaviour.
    Schwarz V; Reis O; Glaser T; Thome J; Hiemke C; Haessler F
    Pharmacopsychiatry; 2014 Jan; 47(1):29-32. PubMed ID: 24307207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium in the treatment of aggression in mentally handicapped patients. A double-blind trial.
    Craft M; Ismail IA; Krishnamurti D; Mathews J; Regan A; Seth RV; North PM
    Br J Psychiatry; 1987 May; 150():685-9. PubMed ID: 3115350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind trial of long-term lithium therapy in mental defectives.
    Naylor GJ; Donald JM; Le Poidevin D; Reid AH
    Br J Psychiatry; 1974 Jan; 124(578):52-7. PubMed ID: 4207106
    [No Abstract]   [Full Text] [Related]  

  • 37. Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study.
    Pöldinger WJ
    Neuropsychobiology; 1984; 11(3):181-6. PubMed ID: 6147789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.
    Reed CR; Kajdasz DK; Whalen H; Athanasiou MC; Gallipoli S; Thase ME
    Curr Med Res Opin; 2012 Jan; 28(1):27-39. PubMed ID: 22106941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cisordinol and Buronil in the elderly. A controlled multi-center double-blind comparison].
    Nygaard HA; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K
    Tidsskr Nor Laegeforen; 1987 Mar; 107(9):827-9. PubMed ID: 3296303
    [No Abstract]   [Full Text] [Related]  

  • 40. A double-blind study of melperone and placebo in hospitalized chronic alcoholics in postintoxication phase.
    Carlsson C; Gullberg B; Höstery U; Christensson E
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):341-5. PubMed ID: 39900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.